Gaps in Capacity in Primary Care in Low-Resource Settings for Implementation of Essential Noncommunicable Disease Interventions

Table 3

Percentage availability of selected essential medicines in primary care facilities in defined areas in eight countries, 2009/2011.

Selected essential medicines	Benin; (𝑛=12)	Eritrea; (𝑛=6)	Sudan; (𝑛=12)	Syria; (𝑛=14)	Bhutan; (𝑛=7)	Sri Lanka; (𝑛=14)	Vietnam; (𝑛=15)	Suriname; (𝑛=10)
Atenolol	8.3	0.0	42.9	14.3	0.0	69.2	93.3	100.0
Enalapril	33.3	0.0	28.6	14.3	0.0	69.2	60.0	30.0
Amlodipine	58.3	0.0	50.0	0.0	0.0	69.2	86.7	80.0
Hydrochlorothiazide	75.0	100.0	35.7	14.3	85.7	69.2	40.0	90.0
Isosorbide dinitrate	0.0	0.0	0.0	21.4	0.0	69.2	60.0	90.0
Frusemide	83.3	50.0	85.7	92.9	14.3	69.2	86.7	100.0
Simvastatin or lovastatin	8.3	0.0	35.7	7.1	0.0	23.1	46.7	50.0
Insulin long acting	0.0	0.0	21.4	21.4	0.0	30.8	0.0	80.0
Insulin soluble	0.0	0.0	28.6	21.4	0.0	30.8	0.0	80.0
Metformin	25.0	0.0	42.9	14.3	0.0	69.2	53.3	100.0
Glibenclamide	41.7	0.0	71.4	21.4	14.3	69.2	33.3	100.0
Beclometasone inhaler	33.3	16.7	21.4	28.6	0.0	15.4	6.7	80.0
Prednisolone	0.0	0.0	42.9	7.1	0.0	69.2	93.3	90.0
Salbutamol inhaler	33.3	100.0	71.4	78.6	0.0	30.8	20.0	90.0
Salbutamol tablets	66.7	100.0	85.7	14.3	100.0	69.2	93.3	90.0
Ipratropium bromide	0.0	0.0	14.3	14.3	0.0	30.8	0.0	20.0
Aspirin	100.0	100.0	100.0	21.4	0.0	69.2	100.0	100.0
Paracetamol	100.0	100.0	92.9	0.0	100.0	69.2	100.0	100.0
Ibuprofen	83.3	100.0	100.0	0.0	100.0	69.2	73.3	80.0
Morphine (oral)	0.0	0.0	14.3	0.0	0.0	15.4	0.0	20.0
Morphine injection	8.3	0.0	14.3	0.0	0.0	38.5	0.0	20.0
Codeine	8.3	0.0	35.7	0.0	0.0	15.4	33.3	60.0
Glucose solution for injection	91.7	0.0	0.0	0.0	57.1	53.8	66.7	80.0
Sodium chloride infusion	91.7	100.0	92.9	35.7	0.0	53.8	100.0	60.0
Benzathine penicillin	50.0	100.0	92.9	57.1	30.8	0.0	60.0	100.0